Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Cardiovasc Pathol. 2014 Aug 15;24(1):19–25. doi: 10.1016/j.carpath.2014.08.004

Figure 1.

Figure 1

Plasma ET-1 among patients with coronary artery disease. a) Plasma levels of ET-1 in patients with CAD<50%, CAD≥50%, and recent MI. * P<.01 CAD≥50% vs. CAD<50%, ***P<.0001 MI vs. CAD≥&<50%, Kruskal Wallis/Dunns post-test). b) Plasma ET-1 among patients with no heart failure (HF), chronic HF, and acute HF, **P<.001 chronic HF vs. no HF, ***P<.0001 acute HF vs. no HF (Kruskil Wallis/Dunns post-test). c) Plasma ET-1 among MI patients with/without acute HF. d) Plasma ET-1 in patients with STEMI and non-STEMI.